<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Balz K</submitter><funding>Philipps-Universität Marburg</funding><funding>NIAID NIH HHS</funding><funding>NIH HHS</funding><pagination>4792</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7910599</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>The outbreak of the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a public health emergency. Asthma does not represent a risk factor for COVID-19 in several published cohorts. We hypothesized that the SARS-CoV-2 proteome contains T cell epitopes, which are potentially cross-reactive to allergen epitopes. We aimed at identifying homologous peptide sequences by means of two distinct complementary bioinformatics approaches. Pipeline 1 included prediction of MHC Class I and Class II epitopes contained in the SARS-CoV-2 proteome and allergens along with alignment and elaborate ranking approaches. Pipeline 2 involved alignment of SARS-CoV-2 overlapping peptides with known allergen-derived T cell epitopes. Our results indicate a large number of MHC Class I epitope pairs incl</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses.</pubmed_title><pmcid>PMC7910599</pmcid><funding_grant_id>R01 AI140134</funding_grant_id><funding_grant_id>U01 AI140498</funding_grant_id><funding_grant_id>R01AI140134-01</funding_grant_id><funding_grant_id>U01AI140498-03</funding_grant_id><pubmed_authors>Balz K</pubmed_authors><pubmed_authors>Skevaki C</pubmed_authors><pubmed_authors>Chen M</pubmed_authors><pubmed_authors>Cemic F</pubmed_authors><pubmed_authors>Renz H</pubmed_authors><pubmed_authors>Kaushik A</pubmed_authors><pubmed_authors>Heger V</pubmed_authors><pubmed_authors>Nadeau K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses.</name><description>The outbreak of the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a public health emergency. Asthma does not represent a risk factor for COVID-19 in several published cohorts. We hypothesized that the SARS-CoV-2 proteome contains T cell epitopes, which are potentially cross-reactive to allergen epitopes. We aimed at identifying homologous peptide sequences by means of two distinct complementary bioinformatics approaches. Pipeline 1 included prediction of MHC Class I and Class II epitopes contained in the SARS-CoV-2 proteome and allergens along with alignment and elaborate ranking approaches. Pipeline 2 involved alignment of SARS-CoV-2 overlapping peptides with known allergen-derived T cell epitopes. Our results indicate a large number of MHC Class I epitope pairs incl</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2026-07-16T01:25:56.532Z</modification><creation>2021-03-05T09:12:44Z</creation></dates><accession>S-EPMC7910599</accession><cross_references><pubmed>33637823</pubmed><doi>10.1038/s41598-021-84320-8</doi></cross_references></HashMap>